5-Aminolaevulinic acid-induced protoporphyrin IX accumulation in tissues: Pharmacokinetics after oral or intravenous administration

Journal of Photochemistry and Photobiology B: Biology

Volumn 44, Issue 1, 1998, Pages 29-38

  Van Den Boogert, Jolanda ^a   Van Hillegersberg, Richard ^a   De Rooij, Felix W M ^a   De Bruin, Ron W F ^a   Edixhoven Bosdijk, Annie ^a   Houtsmuller, Adriaan B ^a   Siersema, Peter D ^a   Wilson, J H Paul ^a   Tilanus, Hugo W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

5 Aminolaevulinic acid; Photodynamic therapy; Porphyrins; Protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID; CREATININE; LIVER ENZYME; PROTOPORPHYRIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; BRAIN; COLON; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG TISSUE LEVEL; DRUG URINE LEVEL; DUODENUM; EPITHELIUM CELL; ESOPHAGUS; HEART; INTRAVENOUS DRUG ADMINISTRATION; JEJUNUM; KIDNEY; KIDNEY FUNCTION TEST; LASER MICROSCOPY; LUNG; MALE; MUSCLE; NERVE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT; SKIN; SPLEEN; STOMACH;

ADMINISTRATION, ORAL; ALANINE TRANSAMINASE; AMINOLEVULINIC ACID; ANIMALS; ASPARTATE AMINOTRANSFERASES; CREATININE; INJECTIONS, INTRAVENOUS; KIDNEY FUNCTION TESTS; MALE; MICROSCOPY, CONFOCAL; PHOTOSENSITIZING AGENTS; PORPHOBILINOGEN; PROTOPORPHYRINS; RATS; RATS, INBRED STRAINS; TISSUE DISTRIBUTION; UREA;

ANIMALIA;

EID: 0032525636     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(98)00102-X     Document Type: Article

References (36)

1. [1] T.J. Dougherty, M.T. Cooper, T.S. Mang, Cutaneous phototoxic occurrences in patients receiving Photophrin, Lasers Surg. Med. 10 (1990) 485-488.
2. [2] C.J. Tralau, H. Barr, A.J. MacRobert, S.G. Bown, Relative merits of porphyrins and pthalocyanine sensitization for photodynamic therapy, in: D. Kessel (Ed.), Photodynamic Therapy of Neoplastic Disease, CRC Press, Boca Raton, FL, 1990, pp. 263-275.
3. [3] R. Van Hillegersberg, J.W.O. Van den Berg, W.J. Kort, O.T. Terpstra, J.H.P. Wilson, Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats, Gastroenterol. 103 (1992) 647-651.
4. [4] M.R. Moore, K.E. McColl, C. Rimmington, A. Goldberg, Porphyrins and enzymes of the heme biosynthetic pathway, in: M.R. Moore (Ed.), Disorders of Porphyrin Metabolism, Plenum, New York, 1987, pp. 21-72.
5. [5] R. Van Hillegersberg, W.J. Kort, J.H.P. Wilson, Current status of photodynamic therapy in oncology, Drugs 48 (1994) 510-527.
6. [6] Q. Peng, T. Warloe, K. Berg, J. Moan, M. Kongshaug, K.E. Giercksky, J.M. Nesland, 5-Aminolevulinic acid-based photodynamic therapy: clinical research and future challenges, Cancer 79 (1997) 2282-2308.
7. [7] G.W. Ibrahim, C.J. Watson, Enterohepatic circulation and conversion of protoporphyrin to bile pigment in man, Proc. Soc. Exp. Biol. Med. 127 (1968) 890-895.
8. 14C, Biochem. 64 (1956) 80-100.
9. [9] S.C. Chang, G. Buonaccorsi, A.J. MacRobert, S.G. Bown, 5-Aminolevulinic acid-induced protoporohyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration, Lasers Surg. Medicine 20 (1997) 254-264.
10. [10] J. Bedwell, A.J. MacRobert, D. Phillips, S.G. Bown, Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model, Br. J. Cancer 65 (1992) 818-824.
11. [11] J.C. Kennedy, R.H. Pettier, Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy, J. Photochem. Photobiol. B: Biol. 14 (1992) 275-292.
12. [12] D.X.G. Divaris, J.C. Kennedy, R.H. Pettier, Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am. J. Pathol. 136 (1990) 891-897.
13. [13] Z. Malik, H. Lugaci, Destruction of erythroleukemic cells by photoactivation of endogenous porphyrins, Br. J. Cancer 56 (1987) 589-595.
14. [14] Z. Hua, S.L. Gibson, T.H. Foster, R. Hilf, Effectiveness of δ-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo, Cancer Res. 55 (1995) 1723-1731.
15. [15] H.U. Bergmeyer, M. Horder, R. Rej, IFCC method for aspartate aminotransferase (L-aspartate: 2-oxoglutarate aminotransferase, EC 2.6.1.1), J. Clin. Chem. Clin. Biochem. 24 (1986) 497-510.
16. [16] S.J. Soldin, B.S. Wan, A.G. Cherian, The measurement of creatinine: a comparison between the Beckman Creatinine Analyzer II and the Selective Analyzer GSA IID, Clin. Biochem. 14 (1981) 165-168.
17. [17] O.H. Lowry, N.J. Rosebrough, A.L. Fair, R.J. Randall, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193 (1951) 265-275.
18. [18] F.W.M. de Rooij, C.M. Hamer, J.H.P. Wilson, Purification of porphobilinogen deaminase from human erythrocytes by fast protein liquid chromatography, Clin. Chim. Acta 162 (1987) 61-68.
19. [19] D. Mauzerall, S. Granick, The occurance and determination of 5-aminolevulinic acid and porphobilinogen in urine, J. Biol. Chem. 219 (1956) 435-446.
20. [20] C.K. Lim, T.J. Peters, Urine and faecal porphyrin profiles by reversed-phase high performance liquid chromatography in the porphyrias, Clin. Chem. Acta 139 (1984) 55-63.
21. [21] J. Chisolm, D.H. Brown, Micro-scale photofluoremetric determination of 'free erythrocyte porphyrin' (protoporphyrin IX), Clin. Chem. 21 (1975) 1669-1682.
22. [22] S.H. Kalman, M. Bengtsson, J. Martensson, Liver function and halothane-diethyl-ether azeotrope anaesthesia, Acta Aneaesthesiol. Scand. 39 (1995) 34-38.
23. [23] K. Hebeda, ALA-induced porphyrin fluorescence in 9L and C6 brain tumors and in normal rat brain, in: K. Hebeda, Thesis: Photodynamic therapy of brain tumors, Amsterdam, 1995, pp. 111-131.
24. [24] C. Abels, P. Heil, M. Dellian, G.E.H. Kuhnle, R. Baumgartner, A.E. Goetz, In vivo kinetics and spectra of 5-aminolaevulinic acid-induced fluorescence in an amelanotic melanoma of the hamster, Br. J. Cancer 70 (1994) 826-833.
25. [25] R. Sroka, W. Beyer, L. Gossner, T. Sassy, S. Stocker, R. Baumgartner, Pharmacokinetics of 5-aminolevulinic acid-induced porphyrins in tumour-bearing mice, J. Photochem. Photobiol. B: Biol. 34 (1996) 13-19.
26. [26] C.S. Loh, A.J. MacRobert, J. Bedwell, J. Regula, N. Krasner, S.G. Bown, Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy, Br. J. Cancer 68 (1993) 41-51.
27. [27] C.S. Loh, D. Vernon, A.J. MacRobert, J. Bedwell, S.G. Bown, S.B. Brown, Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract, J. Photochem. Photobiol. B: Biol. 20 (1993) 47-54.
28. [28] J. Webber, D. Kessel, D. Fromm, Side effects and photosensitization of human tissues after aminolevulinic acid, J. Surg. Res. 68 (1997) 31-37.
29. [29] L.A. Lofgren, A.M. Ronn, C.J. Lee, D. Yoo, B.M. Steinberg, Efficacy of intravenous δ-aminolaevulinic acid photodynamic therapy on rabbit papillomas, Br. J. Cancer 72 (1995) 857-864.
30. [30] K. Rick, H. Stepp, M. Kriegmair, R.M. Huber, K. Jacob, R. Baumgartner, Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood, J. Photochem. Photobiol. B: Biol. 40 (1997) 313-319.
31. [31] R. Van Hillegersberg, J.M. Hekking-Weijma, J.H. Wilson, A. Edixhoven-Bosdijk, W.J. Kort, Adjuvant intraoperative photodynamic therapy diminishes the rate of local recurrence in a rat mammary tumour model, Br. J. Cancer 71 (1995) 733-737.
32. [32] H. Messmann, P. Mlkvy, G. Buonaccorsi, C.L. Davies, A.J. MacRobert, S.G. Bown, Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies, Br. J. Cancer 72 (1995) 589-594.
33. [33] N. Van der Veen, H.L.L.M. Van Leengoed, W.M. Star, In vivo fluoresence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations, Br. J. Cancer 70 (1994) 867-872.
34. [34] H. Fukuda, A.M.C. Batlle, P.A. Riley, Kinetics of porphyrin accumulation in cultured epithelial cells exposed to ALA, Int. J. Biochem. 25 (1993) 1407-1410.
35. [35] P.D. Siersema, J.H.P. Wilson, A. Edixhoven-Bosdijk, F.W.M. de Rooij, H.W. Tilanus, Increased porphobilinogen deaminase activity in pre- and malignant tissue of the esophagus, Gastrointest. Oncol. 41 (1995) A537.
36. [36] L. Rasetti, G.F. Rubino, W. Drago, Ferrochelatase, ALA-dehydrase and ALA-synthetase activity in human tumour tissue, Panminerva Medica 8 (1967) 132-135.